Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact
about
Extended-spectrum beta-lactamases: a clinical updateAntimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Pseudomonas aeruginosa bloodstream infections: risk factors and treatment outcome related to expression of the PER-1 extended-spectrum beta-lactamase.Prevalence of ESBL-producing Pseudomonas aeruginosa isolates in Warsaw, Poland, detected by various phenotypic and genotypic methodsExtended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.BEL-1, a novel clavulanic acid-inhibited extended-spectrum beta-lactamase, and the class 1 integron In120 in Pseudomonas aeruginosaTn5393d, a complex Tn5393 derivative carrying the PER-1 extended-spectrum beta-lactamase gene and other resistance determinants.Prolonged outbreak of infection due to TEM-21-producing strains of Pseudomonas aeruginosa and enterobacteria in a nursing home.Nationwide investigation of extended-spectrum beta-lactamases, metallo-beta-lactamases, and extended-spectrum oxacillinases produced by ceftazidime-resistant Pseudomonas aeruginosa strains in France.Acquisition of a transposon encoding extended-spectrum beta-lactamase SHV-12 by Pseudomonas aeruginosa isolates during the clinical course of a burn patient.Sequence types 235, 111, and 132 predominate among multidrug-resistant pseudomonas aeruginosa clinical isolates in Croatia.Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital.Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatmentComplex genetic structures with repeated elements, a sul-type class 1 integron, and the blaVEB extended-spectrum beta-lactamase gene.Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended-spectrum beta-lactamase in Northern Italy.Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.Management of refractory Pseudomonas aeruginosa infection in cystic fibrosisCarbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.Strain-tailored double-disk synergy test detects extended-spectrum oxacillinases in Pseudomonas aeruginosa.Frequency of PER, VEB, SHV, TEM and CTX-M Genes in Resistant Strains of Pseudomonas aeruginosa Producing Extended Spectrum β-Lactamases.Modification of the susceptibility of gram-negative rods producing ESβLS to β-lactams by the efflux phenomenon.Multidrug-resistant Acinetobacter infections: an emerging challenge to clinicians.Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum beta-lactamase in Warsaw, Poland: further evidence for an international clonal complex.Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community.Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutationPrevalence of ESBLs-producing Pseudomonas aeruginosa isolates from different wards in a Chinese teaching hospital.Treatment of Pseudomonas aeruginosa infection in critically ill patients.The current state of multidrug-resistant gram-negative bacilli in North America.Virulence potential and antibiotic susceptibility pattern of motile aeromonads associated with freshwater ornamental fish culture systems: a possible threat to public health.Detection of SHV type Extended-Spectrum B-lactamase and Risk Factors in Pseudomonas aeruginosa Clinical Isolates.Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.Sequence-selective recognition of extended-spectrum beta-lactamase GES-2 by a competitive, peptide nucleic acid-based multiplex PCR assay.Rapid detection and sequence-specific differentiation of extended-spectrum beta-lactamase GES-2 from Pseudomonas aeruginosa by use of a real-time PCR assayEvaluation of Metallo-β-Lactamase-Production and Carriage of bla-VIM Genes in Pseudomonas aeruginosa Isolated from Burn Wound Infections in Isfahan.Multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii: resistance mechanisms and implications for therapy.Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa.Pyrosequencing as a rapid tool for identification of GES-type extended-spectrum beta-lactamases.Detection of expanded-spectrum β-lactamases in Gram-negative bacteria in the 21st century.Pseudomonas aeruginosa: targeting cell-wall metabolism for new antibacterial discovery and development.Prevalence of PER-1- type Extended-Spectrum Beta-Lactamaes in Clinical Strains of Pseudomonas aeruginosa Isolated from Tabriz, Iran.
P2860
Q24534999-86420C0E-E2CE-42B5-AC33-F70A0204372DQ26739860-2E3C2555-21B2-4645-AD7D-D352736FC4D9Q33236778-DC1F752F-041D-48F0-A19A-990D33E90192Q33848456-0B99AAC3-43DB-4F33-8F30-1F9C64C898E1Q33857230-6D7B1C5E-BFFD-42EF-A110-F35E2E9EA3C3Q33935402-CA44B697-A873-4287-920D-3A6A65D1768AQ33938238-59AAD21F-EE8A-4C82-B25A-BA4A1D08DB4EQ34041685-C8B91DDB-DBB5-4676-8CEC-63714F77AFCDQ34045409-AB2B758D-D75D-4297-A5D8-88BBF4A29EDBQ34108474-A03C42FC-CF5B-49F3-B59B-FE40C45256AAQ34298890-29BAF546-68D4-4875-94E1-E5829997ADA0Q34365963-676FE5BF-C0E5-4CAC-9D3E-CF4996F431A9Q34456773-B59579CE-FA62-489B-9A57-0D227BD4B837Q34648772-59E8A76F-1D0C-469C-9AFA-F31A4D0A2196Q34782040-A4871D35-5FA9-4B92-8460-7FB78F8AC0C6Q35007624-A312AADA-3686-4CCE-8B5B-9E3BDB627265Q35026630-2994957F-47F8-42B5-A549-8E172DD9000BQ35028183-1ABAA5C4-D071-4DF1-825B-72F94892577DQ35066737-456D7C06-8336-4FDA-B9CE-7C38DE36B115Q35148607-FF8EACB8-F439-4834-88EA-363C0777ACA2Q35203279-DE0B3ACC-DEC0-46C7-B226-9F79B07BC282Q35848861-0089C045-2B27-41F0-988E-6A2CAC668B88Q36098603-E370955C-DB8A-4ED1-91D6-2EBB4B38C39DQ36139832-CAF4DEDF-8FE7-4ED4-AE86-27C81B6B8733Q36295397-57051759-0D4B-4771-841A-083E25E28CE4Q36412282-CA4A5E55-27BA-4AD0-9917-633DE378A801Q36607415-26F84327-075A-49A6-B309-A7E01F196CA7Q37069191-0E71320C-DAE3-4098-9F8E-A9E9301D1373Q37159864-A8AFC881-7BBB-41C2-ACB4-895327E19990Q37258014-1605AB7C-3725-4DB1-B03B-AA4E2AE79457Q37302114-2265527A-6704-42D1-A35E-11664D00C166Q37488706-DABA85BE-DE9E-4481-9970-64B14FF63CB1Q37568714-10552C85-4ED0-4B9B-A655-36D4B5F83706Q37597068-75756D40-CF5D-4C65-AA71-1A29F7881CA6Q37656243-8D2FDBF4-E5BB-4C7E-92BC-726821DE2A28Q37756180-C9D4E852-918E-4966-B405-D36DB22ABD8CQ38471803-B889DE30-0380-433F-8540-0BD4436AD321Q38544980-171A377A-0B37-4BEB-9CA5-BFEA99208647Q38844899-AD11613A-1D27-4A6D-AB28-69CF2A6D7EC9Q38865069-C0C74472-EB26-4F81-BA1E-1F10E30A40B0
P2860
Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Ambler class A extended-spectr ...... velopments and clinical impact
@ast
Ambler class A extended-spectr ...... velopments and clinical impact
@en
type
label
Ambler class A extended-spectr ...... velopments and clinical impact
@ast
Ambler class A extended-spectr ...... velopments and clinical impact
@en
prefLabel
Ambler class A extended-spectr ...... velopments and clinical impact
@ast
Ambler class A extended-spectr ...... velopments and clinical impact
@en
P2860
P1476
Ambler class A extended-spectr ...... velopments and clinical impact
@en
P2093
Gerhard F Weldhagen
P2860
P304
P356
10.1128/AAC.47.8.2385-2392.2003
P407
P577
2003-08-01T00:00:00Z